| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 88 companies in the Health Care Providers & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2025 | ALHC Alignment Healthcare, Inc. | Kardes Hakan | Chief Experience Officer | Sell | 31,602 | $16.88 | $533,471.88 | -1.5% | -15.2% | +5.6% | |
| Mar 18, 2025 | COR Cencora, Inc. | Mauch Robert P.46 | President &CEO | Sell | 4,970 | $260.93 | $1,296,822.10 | -4.7% | +10.7% | +23.1% | |
| Mar 18, 2025 | PETS Petmed Express Inc | Nina Capital Holdings Inc. | 10% Owner | Buy | 100,000 | $4.09 | $408,500.00 | +4.2% | -10.9% | -38.4% | |
| Mar 17, 2025 | BTMD Biote Corp. | Heyer Andrew R67 | Director | Buy | 75,000 | $3.95 | $296,042.50 | +4.1% | -0.5% | -66.0% | |
| Mar 17, 2025 | BTMD Biote Corp. | Cone Stephen Mark | Director | Buy | 38,104 | $3.88 | $147,843.52 | +31.0% | -0.5% | -66.0% | |
| Mar 17, 2025 | BTMD Biote Corp. | Beer Marc D | Director | Buy | 107,794 | $3.87 | $417,162.78 | New | -0.5% | -66.0% | |
| Mar 17, 2025 | BTMD Biote Corp. | Christensen Bret | Chief Executive Officer | Buy | 37,595 | $3.87 | $145,492.65 | New | -0.5% | -66.0% | |
| Mar 17, 2025 | LFST Lifestance Health Group, Inc. | Miller Lisa K56 | See Remarks | Sell | 18,845 | $6.90 | $130,030.50 | -5.3% | -25.0% | -4.5% | |
| Mar 17, 2025 | DGX Quest Diagnostics Inc | Prevoznik Michael E52 | SVP &General Counsel | Sell | 4,643 | $170.00 | $789,310.00 | -10.9% | +5.0% | +14.5% | |
| Mar 17, 2025 | ALHC Alignment Healthcare, Inc. | Maroney Dawn Christine56 | President | Sell | 30,000 | $15.99 | $479,688.00 | -1.2% | -9.9% | +11.4% | |
| Mar 17, 2025 | BTMD Biote Corp. | Guines LLC48 | 10% Owner | Buy | 856,609 | $3.25 | $2,784,419.26 | +7.9% | -0.5% | -66.0% | |
| Mar 14, 2025 | CI Cigna Group | Granger Elder50 | Director | Sell | 2,376 | $310.35 | $737,391.60 | -30.3% | +0.8% | -14.6% | |
| Mar 14, 2025 | AGL Agilon Health, Inc. | Venkatachaliah Girish | Chief Technology Officer | Buy | 9,429 | $0.00 | - | +6.3% | -45.9% | -85.2% | |
| Mar 14, 2025 | SGRY Surgery Partners, Inc. | Webb William Trenton72 | American Group President | Sell | 138 | $23.70 | $3,270.60 | -0.2% | -2.1% | -47.5% | |
| Mar 14, 2025 | AGL Agilon Health, Inc. | Sell Steven | CEO &President | Buy | 42,426 | $0.00 | - | +12.9% | -45.9% | -85.2% | |
| Mar 14, 2025 | SGRY Surgery Partners, Inc. | Baldock Jennifer76 | Chief Admin &Dev Officer | Sell | 612 | $23.94 | $14,651.28 | -0.3% | -2.1% | -47.5% | |
| Mar 14, 2025 | AGL Agilon Health, Inc. | Shaker Benjamin76 | Chief Markets Officer | Buy | 11,786 | $0.00 | - | +2.6% | -45.9% | -85.2% | |
| Mar 14, 2025 | SGRY Surgery Partners, Inc. | Burkhalter Danielle75 | Chief Human Resources Officer | Sell | 74 | $23.78 | $1,759.72 | -0.2% | -2.1% | -47.5% | |
| Mar 12, 2025 | ALHC Alignment Healthcare, Inc. | Kardes Hakan | Chief Experience Officer | Sell | 4,856 | $15.43 | $74,916.29 | -0.4% | -6.7% | +9.0% | |
| Mar 12, 2025 | ALHC Alignment Healthcare, Inc. | Scavo Robert L.45 | Chief Information Officer | Sell | 5,313 | $15.43 | $81,966.54 | -0.4% | -6.7% | +9.0% | |
| Mar 12, 2025 | ALHC Alignment Healthcare, Inc. | Freeman Robert Thomas58 | Chief Financial Officer | Sell | 14,692 | $15.43 | $226,661.66 | -0.5% | -6.7% | +9.0% | |
| Mar 12, 2025 | ALHC Alignment Healthcare, Inc. | Maroney Dawn Christine56 | President | Sell | 27,243 | $15.43 | $420,292.71 | -0.6% | -6.7% | +9.0% | |
| Mar 12, 2025 | ALHC Alignment Healthcare, Inc. | Kao John E69 | Chief Executive Officer | Sell | 143,122 | $15.38 | $2,201,771.25 | -1.0% | -6.7% | +9.0% | |
| Mar 11, 2025 | THC Tenet Healthcare Corp | Kerrey J Robert | Director | Sell | 9,525 | $125.43 | $1,194,752.41 | -5.1% | +31.5% | +85.6% | |
| Mar 10, 2025 | SGRY Surgery Partners, Inc. | Doherty David T76 | Chief Financial Officer | Sell | 6,733 | $24.02 | $161,726.66 | -4.3% | -1.3% | -45.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.